Journal of Clinical Pediatrics ›› 2023, Vol. 41 ›› Issue (9): 674-679.doi: 10.12372/jcp.2023.22e0450
• Nervous System Disease • Previous Articles Next Articles
HOU Ruolin, WU Jing(), LI Ling()
Received:
2022-04-18
Online:
2023-09-15
Published:
2023-09-05
Contact:
WU Jing,LI Ling
E-mail:wujing01@xinhuamed.com.cn;liling@xinhuamed.com.cn
HOU Ruolin, WU Jing, LI Ling. Pediatric autoimmune encephalitis with brain MRI showing meningeal thickening and enhancement[J].Journal of Clinical Pediatrics, 2023, 41(9): 674-679.
"
项 目 | 病例1 | 病例2 | |
---|---|---|---|
第一次入院 | 第二次入院 | ||
血自身抗体系列 | dsDNA、抗SSA弱阳性,Ro-52阳性 | ANA核型颗粒型、ANA(1:40)阳性,Ro-52弱阳性 | 阴性 |
脑脊液检测 | |||
细胞数/mm3 | 6↑ | 5 | 6↑ |
体液蛋白定量/mg·L-1 | 691.5↑ | 178.4 | 617.6↑ |
葡萄糖/mmol·L-1 | 3.76 | 4.39 | 8.67 |
氯化物/mmol·L-1 | 125 | 130 | 127.9 |
IgG/mg·L-1 | 68.9↑ | 10.7 | 34.1 |
IgA/mg·L-1 | 5.32↑ | 0.67 | 3.17↑ |
IgM/mg·L-1 | 3.72↑ | 0.15 | 1.74 |
脑电图 | 慢波(3.5~4.0 Hz慢波背景,夹杂1.5~2.5 Hz δ波)伴痫样放电 | 背景慢波(6~7 Hz) | 背景慢波(6~8 Hz) |
[1] |
Lancaster E, Dalmau J. Neuronal autoantigens: patho-genesis, associated disorders and antibody testing[J]. Nat Rev Neurol, 2012, 8(7): 380-390.
doi: 10.1038/nrneurol.2012.99 pmid: 22710628 |
[2] |
Li XJ, Hou C, Wu WL, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis in southern China: analysis of 111 cases[J]. J Neuroimmunol, 2021, 352: 577479.
doi: 10.1016/j.jneuroim.2021.577479 |
[3] |
Wang R, Lai XH, Liu X, et al. Brain magnetic resonance-imaging findings of anti-N-methyl-D-aspartate receptor encephalitis: a cohort follow-up study in Chinese patients[J]. Neurol, 2018, 265(2): 362-369.
doi: 10.1007/s00415-017-8707-5 |
[4] |
Zhang T, Duan Y, Ye J, et al. Brain MRI characteristics of patients with anti-N-methyl-D aspartate receptor encephalitis and their associations with 2-year clinical outcome[J]. AJNR Am J Neuroradiol, 2018, 39(5): 824-829.
doi: 10.3174/ajnr.A5593 |
[5] |
Xiao X, Fu D, Feng L. Hypertrophic pachymeningitis in a southern Chinese population: a retrospective study[J]. Front Neurol, 2020, 11: 565088.
doi: 10.3389/fneur.2020.565088 |
[6] |
Cellucci T, Van Mater H, Graus F, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(2): e663.
doi: 10.1212/NXI.0000000000000663 |
[7] |
Antony J, Hacking C, Jeffree RL. Pachymeningeal enhancement-a comprehensive review of literature[J]. Neurosurg Rev, 2015, 38(4): 649-659.
doi: 10.1007/s10143-015-0646-y pmid: 26264063 |
[8] |
D’Antona L, Jaime Merchan MA, Vassiliou A, et al. Clinical presentation, investigation findings, and treatment outcomes of spontaneous intracranial hypotension syndrome: a systematic review and meta-analysis[J]. JAMA Neurol, 2021, 78(3): 329-337.
doi: 10.1001/jamaneurol.2020.4799 pmid: 33393980 |
[9] | Tian CL, Pu CQ. Dural enhancement detected by magnetic resonance imaging reflecting the underlying causes of cerebral venous sinus thrombosis[J]. Chin Med J (Engl), 2012, 125(8): 1513-1516. |
[10] |
Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis[J]. JAMA Neurol, 2016, 73(11): 1297-1307.
doi: 10.1001/jamaneurol.2016.2549 pmid: 27618707 |
[11] |
Britton PN, Dale RC, Blyth CC, et al. Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study[J]. Clin Infect Dis, 2020, 70(12): 2517-2526.
doi: 10.1093/cid/ciz685 pmid: 31549170 |
[12] |
Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae[J]. Clin Infect Dis, 2001, 32(12): 1674-1684.
pmid: 11360206 |
[13] |
Meyer Sauteur PM, Jacobs BC, Spuesens EB, et al. Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?[J]. PLoS Pathog, 2014, 10(6): e1003983.
doi: 10.1371/journal.ppat.1003983 |
[14] |
Lin JJ, Hsia SH, Wu CT, et al. Mycoplasma pneumoniae-related postencephalitic epilepsy in children[J]. Epilepsia, 2011, 52(11): 1979-1985.
doi: 10.1111/epi.2011.52.issue-11 |
[15] |
Lin JJ, Lin KL, Hsia SH, et al. Analysis of status epilepticus with Mycoplasma pneumoniae Encephalitis[J]. Pediatr Neurol, 2010, 43(1): 41-45.
doi: 10.1016/j.pediatrneurol.2010.02.017 |
[16] |
Narita M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae Infection[J]. Pediatr Neurol, 2009, 41(3): 159-166.
doi: 10.1016/j.pediatrneurol.2009.04.012 |
[17] | Meyer Sauteur PM, Moeller A, Relly C, et al. Swiss national prospective surveillance of paediatric Mycoplasma pneumoniae-associated encephalitis[J]. Swiss Med Wkly, 2016, 146: w14222. |
[18] |
Li Q, Fu N, Han Y, et al. Pediatric autoimmune encephalitis and its relationship with infection[J]. Pediatr Neurol, 2021, 120: 27-32.
doi: 10.1016/j.pediatrneurol.2021.04.001 pmid: 33964702 |
[19] |
Venancio P, Brito MJ, Pereira G, et al. Anti-N-methyl-D-aspartate receptor encephalitis with positive serum antithyroid antibodies, IgM antibodies against Mycoplasma pneumoniae and human herpesvirus 7 PCR in the CSF[J]. Pediatr Infect Dis J, 2014, 33(8): 882-883.
doi: 10.1097/INF.0000000000000408 |
[20] |
Abrantes FF, Moraes MPM, Rezende Filho FM, et al. A clinical approach to hyprtrophic pachymeningitis[J]. Arq Neuropsiquiatr, 2020, 78(12): 797-804.
doi: 10.1590/0004-282x20200073 |
[21] | Bi Z, Shang K, Cao J, et al. Hypertrophic pachymeningitis in Chinese patients: presentation, radiological findings, and clinical course[J]. Biomed Res Int, 2020, 2020: 2926419. |
[22] |
Margoni M, Barbareschi M, Rozzanigo U, et al. Idiopathic hypertrophic cranial pachymeningitis as a rare cause of status epilepticus[J]. Neurol Sci. 2019, 40(10): 2193-2195.
doi: 10.1007/s10072-019-03954-9 pmid: 31154557 |
[23] |
De Virgilio A, de Vincentiis M, Inghilleri M, et al. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease[J]. Immunol Res, 2017, 65(1): 386-394.
doi: 10.1007/s12026-016-8863-1 pmid: 27592235 |
[24] |
Cação G, Calejo M, Alves JE, et al. Clinical features of hypertrophic pachymeningitis in a center survey[J]. Neurol Sci, 2019, 40(3): 543-551.
doi: 10.1007/s10072-018-3689-3 pmid: 30588552 |
[25] |
Jia H, Xie X, Qi F, et al. Anti-NMDAR encephalitis with simultaneous hypertrophic pachymeningitis in a 68-year-old male: a rare case report[J]. BMC Neurol, 2019, 19(1): 215.
doi: 10.1186/s12883-019-1444-x pmid: 31472692 |
[26] |
Ueno T, Kon T, Kaneko K, et al. Contrast enhancement of hypertrophic dura mater in MOG antibodyassociated disease[J]. Neurology, 2019, 93(6): 271-272.
doi: 10.1212/WNL.0000000000007909 |
[27] |
Papathanasiou A, Yeo JM, Humberstone M, et al. MOG antibody-associated hypertrophic pachymeningitis[J]. Mult Scler Relat Disord, 2020, 42: 102074.
doi: 10.1016/j.msard.2020.102074 |
[28] |
Zhang TY, Cai MT, Zheng Y, et al. Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazo lepropionic acid receptor encephalitis: a review[J]. Front Immunol, 2021, 12: 652820.
doi: 10.3389/fimmu.2021.652820 |
[29] |
Diering GH, Huganir RL. The AMPA receptor code of synaptic plasticity[J]. Neuron, 2018, 100(2): 314-329.
doi: S0896-6273(18)30906-1 pmid: 30359599 |
[30] |
Alves de Lima K, Rustenhoven J, Kipnis J. Meningeal immunity and its function in maintenance of the central nervous system in health and disease[J]. Annu Rev Immunol, 2020, 38: 597-620.
doi: 10.1146/annurev-immunol-102319-103410 pmid: 32340575 |
[31] |
Papadopoulos Z, Herz J, Kipnis J. Meningeal lymphatics: from anatomy to central nervous system immune surveil-lance[J]. J Immunol. 2020, 204(2): 286-293.
doi: 10.4049/jimmunol.1900838 pmid: 31907271 |
[32] |
Tan CB, Zhong M, Yao ZX, et al. Anti-GFAP antibody-associated hypertrophic pachymeningitis[J]. Neuropediatrics, 2022, 53(2): 143-145.
doi: 10.1055/s-0042-1742718 pmid: 35148545 |
[33] |
Gong X, Chen C, Liu X, et al. Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in western China[J]. Neurol Neuroimmunol Neuroinflamm, 2021, 8(2): e958.
doi: 10.1212/NXI.0000000000000958 |
[34] |
Holzer FJ, Rossetti AO, Heritier-Barras AC, et al. Antibody-mediated status epilepticus: a retrospective multicenter survey[J]. Eur Neurol, 2012, 68(5): 310-317.
doi: 10.1159/000341143 pmid: 23051892 |
[35] |
Davies G, Irani SR, Coltart C, et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit[J]. Crit Care Med, 2010, 38(2): 679-682.
doi: 10.1097/CCM.0b013e3181cb0968 pmid: 20016378 |
[36] |
Suga H, Yanagida A, Kanazawa N, et al. Status epilepticus suspected autoimmune: neuronal surface antibodies and main clinical features[J]. Epilepsia, 2021, 62(11): 2719-2731.
doi: 10.1111/epi.17055 pmid: 34462918 |
[1] | ZOU Liping. Childhood encephalopathy: a group of diseases associated with various diseases [J]. Journal of Clinical Pediatrics, 2023, 41(9): 641-643. |
[2] | ZHANG Weihua, ZOU Liping, REN Haitao, GUAN Hongzhi. Beware of the pitfalls in diagnosis and treatment of autoimmune encephalitis in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 644-649. |
[3] | HOU Chi, CHEN Wenxiong, LIAO Yinting, WU Wenxiao, TIAN Yang, ZHU Haixia, PENG Bingwei, ZENG Yiru, WU Wenlin, CHEN Zongzong, LI Xiaojing. Clinical analysis of autoimmune glial fibrillary acidic protein astrocytopathy in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 656-660. |
[4] | YANG Yating, CAI Yuehao, FANG Qiong, CHEN Lang, CHEN Qiaobin, LIN Zhi, WU Feifei, LIN Meng. Clinical analysis of idiopathic and symptomatic occipital lobe epilepsy in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 668-673. |
[5] | WU Yuefang, SUN Yanling, WU Wanshui, DU Shuxu, LI Miao, SUN Liming. Analysis of prognostic factors and survival status of group 4 medulloblastoma in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 686-691. |
[6] | SUN Juan, LI Haiying, JIA Peisheng, WANG Huaili. Clinical analysis of fulminant myocarditis in 12 children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 692-696. |
[7] | Reviewer: WANG Chenhui, Reviser: YANG Hui. Research progress on early screening and diagnosis of Crohn's disease in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 708-714. |
[8] | SHEN Nan, DU Bailu. Strategies for the diagnosis, treatment, and management of invasive fungal infections in children with hematologic neoplasms [J]. Journal of Clinical Pediatrics, 2023, 41(8): 571-577. |
[9] | XU Beixue, LIU Quanbo. Clinical analysis of 195 children with invasive pulmonary fungal infection [J]. Journal of Clinical Pediatrics, 2023, 41(8): 584-588. |
[10] | CHEN Hongyu, LIU Zihao, WANG Heping, LIAO Cuijuan, LI Li, WANG Wenjian, LAI Jianwei. Role of nontypeable Haemophilus influenzae biofilms in chronic pulmonary infection in children [J]. Journal of Clinical Pediatrics, 2023, 41(8): 589-593. |
[11] | KANG Lei, GUO Fang, LI Lifang, BAI Xinfeng, CHENG Caiyun, XU Meixian. Value of metagenomic next-generation sequencing in children with visceral leishmaniasis associated with hemolytic histiocytosis [J]. Journal of Clinical Pediatrics, 2023, 41(8): 594-598. |
[12] | WU Xiaoling, LYU Tiewei. Clinical analysis of idiopathic left ventricular tachycardia in children [J]. Journal of Clinical Pediatrics, 2023, 41(8): 599-603. |
[13] | SUN Zhicai, LIU Yuling, LI Xiaolin, PAN Xiaofen. Clinical analysis of 15 children with primary nephrotic syndrome complicated with adrenal crisis [J]. Journal of Clinical Pediatrics, 2023, 41(8): 610-612. |
[14] | WANG Hongxia, PAN Xiang, LU Jun. Report a case of α-ketoadipic aciduria caused by compound heterozygous variant of DHTKD1 gene [J]. Journal of Clinical Pediatrics, 2023, 41(8): 624-628. |
[15] | XI Bixin, HU Qun, LIU Aiguo. Research advances of the bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplant in children [J]. Journal of Clinical Pediatrics, 2023, 41(8): 629-633. |
|